CIENCIAS FARMACÉUTICAS
Département
Hospital Regional Universitario de Málaga
Málaga, EspañaPublications en collaboration avec des chercheurs de Hospital Regional Universitario de Málaga (7)
2023
-
Comments on: Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children
Pharmacological Research
-
Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children
Pharmacological Research, Vol. 194
2022
-
Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study
Inflammatory bowel diseases, Vol. 28, Núm. 11, pp. 1725-1736
-
Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab
Journal of Clinical Medicine, Vol. 11, Núm. 15
2021
-
Pharmacogenetics of trough serum anti-TNF levels in paediatric inflammatory bowel disease
British Journal of Clinical Pharmacology, Vol. 87, Núm. 2, pp. 447-457
2020
-
Genetic Predictors of Long-term Response to Antitumor Necrosis Factor Agents in Pediatric Inflammatory Bowel Disease
Journal of pediatric gastroenterology and nutrition, Vol. 71, Núm. 4, pp. 508-515
2008
-
A carboxylesterase 2 gene polymorphism as predictor of capecitabine on response and time to progression
Current Drug Metabolism, Vol. 9, Núm. 4, pp. 336-343